SENP1-IN-3
SENP1-IN-3 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 17. SENP1-IN-3 is developed for tumor radiosensitivity enhancement[1].
Product Specifications
CAS Number
[2416910-59-1]
UNSPSC
12352211
Target
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/senp1-in-3.html
Purity
99.92
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1(C)[C@@H](OC(C)=O)CC[C@]2(C)[C@@]3([H])CC=C4[C@]5([H])[C@@H](C)[C@H](C)CC[C@@](C(N(C)CC(NC)=O)=O)5CC[C@](C)4[C@@](C)3CC[C@@]12[H]
Molecular Formula
C36H58N2O4
Molecular Weight
582.86
References & Citations
[1]Li, Yiliang, et al. Preparation of ursolic acid derivatives useful as SENP1 inhibitors and tumor radiosensitizer. CN110627860A.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RanBP17 (RanGTP-Binding Protein, RanBP 17, RanBP-17) (MaxLight 750)
RanBP17 (RanGTP-Binding Protein, RanBP 17, RanBP-17) (MaxLight 750)
NOXA1, CT (NOXA1, P51NOX, NADPH oxidase activator 1, Antigen NY-CO-31, NCF2-like protein, P67phox-like factor, p51-nox)
NOXA1, CT (NOXA1, P51NOX, NADPH oxidase activator 1, Antigen NY-CO-31, NCF2-like protein, P67phox-like factor, p51-nox)